Tear Science Presenting Company Presentation from OIS@AAO 2014

1. 1
1

2. 22

3. 33

4. 44

5. 55

6. 6
Be#er!!
6.2!±!3.7!
17.3!±!11.2! 17.8!±!10.6! 18.7!±!10.9! 18.8!±!9.8! 17.3!±!9.1!
0!
5!
10!
15!
20!
25!
Baseline* 1*Month* 3*Months* 6*Months* 9*Months* 12*Months*
Meibomian*Gland*(MG)*Score*****
One!LipiFlow!Treatment!!
**N=202*Eyes*******************N=192*Eyes******************N=196*Eyes******************N=182*Eyes ***************N=164*Eyes*****************N=162*Eyes*
*
p<0.0001*!

7. 7
45.6!±!21.2!
26.6!±!21.6!
21.6!±!19.8! 20.2!±!19.3! 19.0!±!17.6! 21.6!±!21.3!
0!
5!
10!
15!
20!
25!
30!
35!
40!
45!
50!
Baseline* 1*Month* 3*Months* 6*Months* 9*Months* 12*Months*
Ocular*Surface*Disease*Index*
(OSDI)*Score*
One!LipiFlow!Treatment!!
**N=202*Eyes*******************N=192*Eyes******************N=196*Eyes******************N=182*Eyes ***************N=164*Eyes*****************N=162*Eyes*
*
Better**
p<0.0001*!

8. 88

9. 9
Treat
9
Korb Meibomian Gland Evaluator™
LipiFlow®
LipiView® II
Identify & Diagnose

10. 10